Horus' Computer-Enhanced Diagnostics
Horus is applying neural nets and other artificial intelligence techniques to the practice of pathology in order to improve the accuracy of certain diagnostic tests. The bet is that computer enhancements can help diagnostic companies deal with pricing pressures and intense competition by better differentiating their products and increasing the value of specific diagnostic tests.
You may also be interested in...
In the current economy, e.l.f.’s value messaging is resonating with new consumers, contributing to an 8% jump in its fiscal 2021 first-quarter sales. The company expects continued volatility, but is optimistic about its robust digital game, growing skin-care clout and a newly announced partnership with Alicia Keys that it says will yield much more than “just another celebrity beauty line.”
Most of the major orthopaedics companies beat analyst expectations in the second quarter, but the ongoing COVID-19 pandemic raises uncertainties regarding procedure volumes for the rest of this year. See what Zimmer Biomet’s CEO Bryan Hanson said about it here.
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.